CA2155843C - Nouveaux derives de l'uree; preparation et utilisation - Google Patents
Nouveaux derives de l'uree; preparation et utilisation Download PDFInfo
- Publication number
- CA2155843C CA2155843C CA002155843A CA2155843A CA2155843C CA 2155843 C CA2155843 C CA 2155843C CA 002155843 A CA002155843 A CA 002155843A CA 2155843 A CA2155843 A CA 2155843A CA 2155843 C CA2155843 C CA 2155843C
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- alkoxycarbonyl
- hydrogen
- aryl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Closures For Containers (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4309867A DE4309867A1 (de) | 1993-03-26 | 1993-03-26 | Neue Harnstoffderivate, ihre Herstellung und Verwendung |
DEP4309867.3 | 1993-03-26 | ||
PCT/EP1994/000713 WO1994022907A1 (fr) | 1993-03-26 | 1994-03-09 | Nouveaux derives d'uree, leur preparation et leur utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2155843A1 CA2155843A1 (fr) | 1994-10-13 |
CA2155843C true CA2155843C (fr) | 2004-09-21 |
Family
ID=6483938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002155843A Expired - Fee Related CA2155843C (fr) | 1993-03-26 | 1994-03-09 | Nouveaux derives de l'uree; preparation et utilisation |
Country Status (14)
Country | Link |
---|---|
US (1) | US5703050A (fr) |
EP (1) | EP0689549B1 (fr) |
JP (1) | JP3597862B2 (fr) |
KR (1) | KR100418144B1 (fr) |
AT (1) | ATE167483T1 (fr) |
AU (1) | AU679509B2 (fr) |
CA (1) | CA2155843C (fr) |
DE (2) | DE4309867A1 (fr) |
DK (1) | DK0689549T3 (fr) |
ES (1) | ES2119187T3 (fr) |
HU (1) | HU219483B (fr) |
IL (1) | IL109135A (fr) |
WO (1) | WO1994022907A1 (fr) |
ZA (1) | ZA942124B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4427979A1 (de) | 1993-11-15 | 1996-02-15 | Cassella Ag | Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung |
US6248713B1 (en) | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
AU702487B2 (en) | 1995-08-30 | 1999-02-25 | G.D. Searle & Co. | Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
CA2242877A1 (fr) * | 1996-01-16 | 1997-07-24 | Merck & Co., Inc. | Antagonistes du recepteur integrine |
DE19622489A1 (de) | 1996-06-05 | 1997-12-11 | Hoechst Ag | Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters |
US6239108B1 (en) | 1996-07-11 | 2001-05-29 | Biogen, Inc. | Cell adhesion inhibitors |
DK0914605T3 (da) | 1996-07-25 | 2007-09-10 | Biogen Idec Inc | Molekylemodel for VLA-4-inhibitorer |
US6686350B1 (en) | 1996-07-25 | 2004-02-03 | Biogen, Inc. | Cell adhesion inhibitors |
PL198189B1 (pl) | 1998-05-28 | 2008-06-30 | Biogen Idec Ma | (R)-N-{[4-{[(2-metylofenyloamino)-karbonylo]amino}fenylo]acetylo}-L-prolilo-3-metylo]-ß-alanina, jej zastosowanie i kompozycja farmaceutyczna ją zawierająca |
US6420403B1 (en) * | 1998-10-29 | 2002-07-16 | Edwin J. Iwanowicz | Inhibitors of IMPDH enzyme |
JP2003506491A (ja) | 1999-08-13 | 2003-02-18 | バイオジェン インコーポレイテッド | 細胞接着インヒビター |
RU2001114518A (ru) * | 1999-09-29 | 2003-04-20 | Орто-Макнейл Фармасьютикал, Инк. (Us) | Изонипекотамиды для лечения опосредованных интегринами нарушений |
EP1162194A1 (fr) * | 2000-06-06 | 2001-12-12 | Aventis Pharma Deutschland GmbH | Dérivés de (thio)-urée inhibiteurs du facteur VIIa, procédé de leur préparation et leur utilisation |
US6875743B1 (en) | 2000-11-28 | 2005-04-05 | Biogen, Inc. | Cell adhesion inhibitors |
DE10063008A1 (de) * | 2000-12-16 | 2002-06-20 | Merck Patent Gmbh | Carbonsäureamidderivate |
US7081460B2 (en) * | 2001-04-09 | 2006-07-25 | Ortho-Mcneil Pharmaceutical, Inc. | Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
EP1270551A1 (fr) * | 2001-06-26 | 2003-01-02 | Aventis Pharma Deutschland GmbH | Dérivés d'urée avec une activité antiprotéolytique |
CN113717079B (zh) * | 2021-09-30 | 2023-03-31 | 内蒙古康普药业有限公司 | 一种甲氧氯普胺双胺新杂质的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5051405A (en) * | 1989-10-10 | 1991-09-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptides and pseudopeptides |
US5053392A (en) * | 1989-12-01 | 1991-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors |
DE4009506A1 (de) * | 1990-03-24 | 1991-09-26 | Hoechst Ag | Hydantoinderivate |
EP0570507A4 (en) * | 1991-02-05 | 1994-09-21 | Smithkline Beecham Corp | Anti-aggregatory peptides containing an aromatic ester or amide |
US5321034A (en) * | 1991-05-07 | 1994-06-14 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
ATE142641T1 (de) * | 1991-05-13 | 1996-09-15 | Fujisawa Pharmaceutical Co | Neue peptid-verbindungen und verfahren zur herstellung davon |
DE4126277A1 (de) * | 1991-08-08 | 1993-02-11 | Cassella Ag | Hydantoinderivate |
US5272162A (en) * | 1992-07-02 | 1993-12-21 | G. D. Searle & Co. | Platelet aggregation inhibitors |
US5314902A (en) * | 1993-01-27 | 1994-05-24 | Monsanto Company | Urea derivatives useful as platelet aggregation inhibitors |
-
1993
- 1993-03-26 DE DE4309867A patent/DE4309867A1/de not_active Withdrawn
-
1994
- 1994-03-09 CA CA002155843A patent/CA2155843C/fr not_active Expired - Fee Related
- 1994-03-09 AU AU63754/94A patent/AU679509B2/en not_active Ceased
- 1994-03-09 US US08/513,815 patent/US5703050A/en not_active Expired - Lifetime
- 1994-03-09 EP EP94911129A patent/EP0689549B1/fr not_active Expired - Lifetime
- 1994-03-09 KR KR1019950704123A patent/KR100418144B1/ko not_active IP Right Cessation
- 1994-03-09 JP JP52159194A patent/JP3597862B2/ja not_active Expired - Lifetime
- 1994-03-09 HU HU9502792A patent/HU219483B/hu not_active IP Right Cessation
- 1994-03-09 DE DE59406279T patent/DE59406279D1/de not_active Expired - Lifetime
- 1994-03-09 DK DK94911129T patent/DK0689549T3/da active
- 1994-03-09 AT AT94911129T patent/ATE167483T1/de not_active IP Right Cessation
- 1994-03-09 WO PCT/EP1994/000713 patent/WO1994022907A1/fr active IP Right Grant
- 1994-03-09 ES ES94911129T patent/ES2119187T3/es not_active Expired - Lifetime
- 1994-03-25 IL IL10913594A patent/IL109135A/en active IP Right Grant
- 1994-03-25 ZA ZA942124A patent/ZA942124B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US5703050A (en) | 1997-12-30 |
IL109135A (en) | 1999-03-12 |
JP3597862B2 (ja) | 2004-12-08 |
JPH08508267A (ja) | 1996-09-03 |
AU679509B2 (en) | 1997-07-03 |
AU6375494A (en) | 1994-10-24 |
ZA942124B (en) | 1994-11-10 |
HU9502792D0 (en) | 1995-11-28 |
DE4309867A1 (de) | 1994-09-29 |
EP0689549B1 (fr) | 1998-06-17 |
EP0689549A1 (fr) | 1996-01-03 |
ES2119187T3 (es) | 1998-10-01 |
ATE167483T1 (de) | 1998-07-15 |
DE59406279D1 (de) | 1998-07-23 |
WO1994022907A1 (fr) | 1994-10-13 |
HUT73409A (en) | 1996-07-29 |
IL109135A0 (en) | 1994-06-24 |
DK0689549T3 (da) | 1999-02-01 |
KR960701087A (ko) | 1996-02-24 |
HU219483B (hu) | 2001-04-28 |
KR100418144B1 (ko) | 2004-05-07 |
CA2155843A1 (fr) | 1994-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5554594A (en) | Imidazolidine derivatives | |
US5397796A (en) | 2,4-dioxoimidazolidine compounds and compositions, and processes for administering same | |
US5658935A (en) | Heterocycles, their preparation and their use | |
CA2155843C (fr) | Nouveaux derives de l'uree; preparation et utilisation | |
US5424293A (en) | Phenylimidazolidine derivatives and their use | |
US5389614A (en) | Hydantoin derivatives | |
US5981492A (en) | Substituted 5-membered ring heterocycles, their preparation and their use | |
CA2130174C (fr) | Derives de la 4-oxo-2-thioxoimidazolidine utilises comme inhibiteurs de l'agregation plaquettaire | |
US5681838A (en) | Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation | |
CA2154477C (fr) | Derives de substitution amines; leur preparation et leur utilisation comme inhibiteurs de l'agregation des thrombocytes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |